z-logo
Premium
A critical role for PKC‐theta‐mediated T cell survival in cardiac allograft rejection
Author(s) -
Sun Zuoming,
Manicassamy Santhkumar,
Yin Dengping,
Molinero Luciana L,
Alegre MarisaLuisa Alegre
Publication year - 2008
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.22.1_supplement.662.8
Subject(s) - cd154 , adoptive cell transfer , protein kinase c , t cell , transplantation , microbiology and biotechnology , apoptosis , t cell receptor , biology , immunology , chemistry , medicine , signal transduction , immune system , cd40 , cytotoxic t cell , in vitro , biochemistry
PKC‐theta mediates the critical TCR signals required for T cell activation. Previously we have shown that in response to TCR stimulation, PKC‐theta−/− T cells undergo apoptosis due to greatly reduced levels of the anti‐apoptotic molecule, Bcl‐xL. Here we demonstrate that PKC‐theta‐regulated expression of Bcl‐xL is essential for T cell‐mediated cardiac allograft rejection. Rag1−/− mice reconstituted with wild type (WT) T cells readily rejected fully mismatched cardiac allografts, whereas, Rag1−/− mice reconstituted with PKC‐theta−/− T cells failed to promote rejection. Transgenic expression of Bcl‐xL in PKC‐theta−/− T cells was sufficient to restore cardiac allograft rejection, suggesting that PKC‐theta‐regulated survival is required for T cell‐mediated cardiac allograft rejection in this adoptive transfer model. In contrast to adoptive transfer experiments, intact PKC‐theta−/− mice displayed delayed, but successful cardiac allograft rejection, suggesting the potential compensation for PKC‐theta function. Finally, a sub‐therapeutic dose of anti‐CD154 antibody, that was not sufficient to prevent cardiac allograft rejection in the WT mice, prevented heart rejection in the PKC‐theta−/− mice. Thus, in combination with other treatments, inhibition of PKC‐theta may facilitate achieving long‐term survival of allografts.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here